Plain-English translation of NCT01372800 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are studying a protein hormone called adiponectin that your body naturally produces. This 5-year study will follow about 30,000 people in China to see how levels of this protein in the blood may be linked to heart disease, stroke, and related conditions.
Scientists have noticed that people with heart disease and stroke often have lower levels of this natural protein. Understanding this connection better could help doctors identify who is at higher risk and develop new ways to prevent these serious conditions.
You likely qualify if…
You likely don't qualify if…
You would donate blood samples at the beginning of the study and at follow-up visits over 5 years. Researchers will measure the protein hormone levels in your blood and track whether you develop heart disease or stroke during that time. The study involves regular check-ins to monitor your health status, but does not involve taking any new medication.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
China
~30,000 participants
Started
May 2011
Primary completion
October 2026
Age range
18 Years – 85 Years
Last updated on clinicaltrials.gov in February 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Ling Tao, M.D Ph.D
Xijing Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.